FALLICA, ANTONINO NICOLO'
 Distribuzione geografica
Continente #
NA - Nord America 257
EU - Europa 206
AF - Africa 49
AS - Asia 10
OC - Oceania 2
SA - Sud America 1
Totale 525
Nazione #
US - Stati Uniti d'America 254
IT - Italia 114
IE - Irlanda 43
CI - Costa d'Avorio 41
DE - Germania 23
CN - Cina 9
RU - Federazione Russa 8
SN - Senegal 8
UA - Ucraina 4
CA - Canada 3
CH - Svizzera 3
ES - Italia 3
GB - Regno Unito 3
AU - Australia 2
SE - Svezia 2
CL - Cile 1
FR - Francia 1
LU - Lussemburgo 1
NL - Olanda 1
SG - Singapore 1
Totale 525
Città #
Chandler 112
Dublin 43
Abidjan 41
Catania 25
Ashburn 21
Bremen 11
Cambridge 11
Lawrence 11
Andover 10
Dakar 8
Redmond 6
Wilmington 5
Moscow 4
Arezzo 3
Boardman 3
Des Moines 3
Gela 3
Nanjing 3
Padova 3
Palermo 3
Rome 3
Cagliari 2
Ferrara di Monte Baldo 2
Foggia 2
Los Angeles 2
Ludwigshafen 2
Madrid 2
Nanchang 2
Toronto 2
Atripalda 1
Augusta 1
Canberra 1
Corigliano Calabro 1
Dallas 1
Edinburgh 1
Esslingen am Neckar 1
Fairfield 1
Ferrara 1
Hebei 1
Latina 1
Leawood 1
Luxembourg 1
Melbourne 1
New York 1
Novara 1
Ottawa 1
Phoenix 1
Piazza Armerina 1
Piedimonte Etneo 1
Piemonte 1
Porto San Giorgio 1
Redwood City 1
Reggio Calabria 1
Rimini 1
Santiago 1
Seattle 1
Shenyang 1
Turin 1
Villafranca Tirrena 1
Zhengzhou 1
Totale 379
Nome #
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 80
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents 65
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 50
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective 47
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 45
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 45
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors 45
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation 40
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 36
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects 29
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 24
The potential role of sildenafil in cancer management through epr augmentation 23
The Promise of Nanotechnology in Personalized Medicine 11
Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections 11
Targeting del sistema enzimatico dell'eme ossigenasi come nuovo approccio nella terapia antitumorale 9
Totale 560
Categoria #
all - tutte 1.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/202018 7 2 0 0 0 1 3 0 1 2 1 1
2020/202132 0 0 3 9 8 0 2 2 0 1 4 3
2021/2022130 11 8 24 3 16 2 23 10 7 5 0 21
2022/2023264 26 18 7 45 23 45 1 36 45 2 12 4
2023/2024103 4 13 4 3 12 55 1 2 3 6 0 0
Totale 560